• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    5/28/24 1:24:16 PM ET
    $ABL
    $AGIO
    $AKAN
    $APDN
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABL alert in real time by email

    Shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) fell sharply during Tuesday's session after the company announced the pricing of a $12 million public offering.

    Applied DNA Sciences shares tumbled 67.5% to $0.6468 on Tuesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Sharps Technology, Inc. (NASDAQ:STSS) shares climbed 207% to $0.6579 after jumping around 13% on Friday.
    • Insmed Incorporated (NASDAQ:INSM) jumped 110% to $46.20 after the company announced topline results from ASPEN Phase 3 study met its primary endpoint.
    • Pineapple Energy Inc. (NASDAQ:PEGY) shares gained 91.5% to $0.3411 after the company on Friday announced its SUNation subsidiary signed a 1.95-megawatt project.
    • Calliditas Therapeutics AB (NASDAQ:CALT) shares gained 74.6% to $38.10 after the company’s board recommended the acceptance of Asahi Kasei’s tender offer.
    • Visionary Holdings Inc. (NASDAQ:GV) rose 68% to $0.3350. Visionary Holdings said that the company has successfully transformed into a high-innovation and high growth company.
    • Oblong, Inc. (NASDAQ:OBLG) surged 57% to $0.2841.
    • Latam Logistic Properties, S.A. (NYSE:LPA) rose 45.2% to $20.47.
    • Predictive Oncology Inc. (NASDAQ:POAI) jumped 37% to $2.1801 after the company announced results from its ovarian caner study with UPMC Magee-Womens Hospital.
    • Trinity Place Holdings Inc. (NASDAQ:TPHS) rose 35% to $0.1837.
    • Exicure, Inc. (NASDAQ:XCUR) gained 31% to $0.4359.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) rose 30% to $1.1000.
    • Kuke Music Holding Limited (NYSE:KUKE) gained 24.2% to $3.2781. Kuke Music signed a non-binding term sheet with Naxos One Holding.
    • Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) rose 22% to $38.29 after the company announced it agreed to sell its rights to its 15% royalty on potential U.S. net sales of Servier’s vorasidenib to Royalty Pharma.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) gained 21% to $36.63 after the company announced it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in CF patients for ARCT-032.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 19.3% to $0.1205 after dipping over 10% on Friday.
    • Ocean Power Technologies, Inc. (NASDAQ:OPTT) shares gained 16.7% to $0.2240 after gaining around 5% on Friday.
    • GameStop Corp. (NYSE:GME) gained 14.4% to $0.3411 after the company announced it has completed its at-the-market equity offering program, which was previously announced.
    • Corcept Therapeutics Incorporated (NASDAQ:CORT) climbed 13.7% to $31.20 after the company announced that its Phase 3 GRACE trial met its primary endpoint.
    • Forward Air Corporation (NASDAQ:FWRD) rose 13% to $13.93.
    • NuScale Power Corporation (NYSE:SMR) gained 11.7% to $8.68 after jumping over 16% on Friday.
    • Nukkleus Inc. (NASDAQ:NUKK) rose 10.9% to $1.0201.
    • Abacus Life, Inc. (NASDAQ:ABL) gained 10.1% to $11.78.
    • Oklo Inc. (NYSE:OKLO) rose 10.1% to $11.18.
    • HubSpot, Inc. (NYSE:HUBS) gained 6.9% to $631.00.

    Losers

    • Marpai, Inc. (NASDAQ:MRAI) shares fell 54.7% to $0.6468 after the company announced its intention to withdraw from the Nasdaq hearings process.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) shares fell 47.4% to $0.5170 after surging 428% on Friday.
    • Sintx Technologies, Inc. (NASDAQ:SINT) fell 41% to $8.00.
    • Netcapital Inc. (NASDAQ:NCPL) dipped 27.7% to $0.1390 after the company announced that it entered into definitive agreement for the immediate exercise of $2.2 million of certain outstanding Series A-2 warrants.
    • OneMedNet Corporation (NASDAQ:ONMD) shares fell 24.4% to $1.77 after jumping 56% on Friday. OneMedNet, last week, highlighted a ‘five-fold expansion’ of its iRWD network and platform.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) fell 22.8% to $2.61.
    • Akanda Corp. (NASDAQ:AKAN) shares fell 18.5% to $3.35 following a 72% surge on Friday. The international medical cannabis company implemented a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, according to a recent exchange filing.
    • SolarMax Technology, Inc. (NASDAQ:SMXT) fell 17.8% to $8.25.
    • G1 Therapeutics, Inc. (NASDAQ:GTHX) declined 17.6% to $3.37.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) fell 15.6% to $1.8399.
    • HilleVax, Inc. (NASDAQ:HLVX) fell 13.6% to $11.14.
    • Celsius Holdings, Inc. (NASDAQ:CELH) dipped 13.3% to $82.08.
    • Ryde Group Ltd. (NYSE:RYDE) declined 12.6% to $9.38.
    • Novavax, Inc. (NASDAQ:NVAX) fell 12.4% to $13.56.
    • NWTN Inc. (NASDAQ:NWTN) declined 12.3% to $3.52. NWTN received expected notification from the Nasdaq related to delayed annual report on Form 20-F.
    • DraftKings Inc. (NASDAQ:DKNG) dipped 11% to $36.29 after the Illinois Senate approved a 2025 budget that includes a sports betting tax hike.
    • Merus N.V. (NASDAQ:MRUS) fell 9.5% to $54.28 as the company revealed interim results for bispecific antibody petosemtamab with pembrolizumab at 2024 American Society of Clinical Oncology Annual Meeting.
    • Moderna, Inc. (NASDAQ:MRNA) dipped 9.2% to $151.28.
    • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) declined 9.1% to $112.24 after RBC Capital downgraded the stock from Outperform to Sector Perform.
    • Minim, Inc. (NASDAQ:MINM) shares fell 8.6% to $3.91 after gaining 33% on Friday.
    • Applied UV, Inc. (NASDAQ:AUVI) shares fell 8.5% to $0.2879. Applied UV shares fell around 34% on Friday after the company reportedly filed for Chapter 11 bankruptcy.
    • Loar Holdings Inc. (NYSE:LOAR) declined 7% to $51.36.
    • Sea Limited (NYSE:SE) declined 6% to $67.75 after the company’s Shopee was reportedly accused of suspected anti-competition breaches in Indonesia.
    • Hello Group Inc. (NASDAQ:MOMO) fell 5.8% to $5.20 following first-quarter results.

    Now Read This: $1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

    Get the next $ABL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABL
    $AGIO
    $AKAN
    $APDN

    CompanyDatePrice TargetRatingAnalyst
    NuScale Power Corporation
    $SMR
    2/11/2026Buy → Hold
    TD Cowen
    DraftKings Inc.
    $DKNG
    2/6/2026$41.00 → $32.00Outperform
    Bernstein
    HubSpot Inc.
    $HUBS
    1/29/2026$465.00 → $385.00Outperform
    BMO Capital Markets
    Sarepta Therapeutics Inc.
    $SRPT
    1/28/2026$20.00Equal Weight
    Barclays
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    Insmed Incorporated
    $INSM
    1/28/2026$231.00Overweight
    Barclays
    Insmed Incorporated
    $INSM
    1/23/2026$212.00Buy
    Roth Capital
    Arcturus Therapeutics Holdings Inc.
    $ARCT
    1/23/2026$20.00Buy
    Roth Capital
    More analyst ratings

    $ABL
    $AGIO
    $AKAN
    $APDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Chief Executive Officer Gross Harrison R. bought $1,980 worth of shares (1,500 units at $1.32), increasing direct ownership by 12% to 13,733 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/22/26 11:29:05 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $ABL
    $AGIO
    $AKAN
    $APDN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 6, 2024 - FDA Roundup: December 6, 2024

    For Immediate Release: December 06, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA published the draft guidance, “Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics,” which proposes updates to certain agency policies and procedures regarding accelerated approval. Topics addressed by this

    12/6/24 3:09:02 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ABL
    $AGIO
    $AKAN
    $APDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Falconx Holdings Ltd sold $1,490,755 worth of shares (769,320 units at $1.94) and exercised 461,538 in-the-money shares at a strike of $0.00 (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    2/13/26 4:45:04 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Mock James M covered exercise/tax liability with 1,278 shares and was granted 2,630 shares, increasing direct ownership by 3% to 45,224 units (SEC Form 4)

    4 - Moderna, Inc. (0001682852) (Issuer)

    2/13/26 4:41:15 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Legal Officer Klinger Shannon Thyme was granted 2,630 shares and covered exercise/tax liability with 1,334 shares, increasing direct ownership by 2% to 54,527 units (SEC Form 4)

    4 - Moderna, Inc. (0001682852) (Issuer)

    2/13/26 4:36:40 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABL
    $AGIO
    $AKAN
    $APDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    NuScale Power downgraded by TD Cowen

    TD Cowen downgraded NuScale Power from Buy to Hold

    2/11/26 7:50:27 AM ET
    $SMR
    Metal Fabrications
    Industrials

    Bernstein reiterated coverage on DraftKings with a new price target

    Bernstein reiterated coverage of DraftKings with a rating of Outperform and set a new price target of $32.00 from $41.00 previously

    2/6/26 8:25:47 AM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    BMO Capital Markets reiterated coverage on HubSpot with a new price target

    BMO Capital Markets reiterated coverage of HubSpot with a rating of Outperform and set a new price target of $385.00 from $465.00 previously

    1/29/26 6:50:55 AM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    $ABL
    $AGIO
    $AKAN
    $APDN
    SEC Filings

    View All

    SEC Form 424B3 filed by Nukkleus Inc.

    424B3 - T3 Defense Inc. (0001787518) (Filer)

    2/13/26 5:21:20 PM ET
    $NUKK
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.

    SCHEDULE 13G/A - Innovative Eyewear Inc (0001808377) (Subject)

    2/13/26 4:44:25 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Loar Holdings Inc.

    SCHEDULE 13G/A - Loar Holdings Inc. (0002000178) (Subject)

    2/13/26 4:30:02 PM ET
    $LOAR
    Military/Government/Technical
    Industrials

    $ABL
    $AGIO
    $AKAN
    $APDN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Visionary Holdings Inc. Secures $450,000 in Debt Financing

    TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ:GV) ("Visionary" or the "Company") announced today that in December 2025 it entered into a securities purchase agreement with an existing institutional investor (the "Investor"). In connection with the transaction, the Company issued to the Investor a senior secured convertible promissory note in the principal amount of $500,000 (the "December 2025 Note") in exchange for gross proceeds of $450,000. As previously disclosed, on January 31, 2025, the Company issued to the Investor a senior secured convertible promissory note in the principal amount of $1,500,000 (the "January 2025 Note") pursuant to a securities purch

    2/13/26 4:30:00 PM ET
    $GV
    Other Consumer Services
    Real Estate

    Insmed To Present at March 2026 Investor Conferences

    BRIDGEWATER, N.J., Feb. 13, 2026 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences: 46th Annual TD Cowen Healthcare Conference in Boston, on Monday, March 2, 2026, at 9:50 a.m. ET.Leerink Partners Global Healthcare Conference in Miami, on Tuesday, March 10, 2026, at 8:00 a.m. ET.These events will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a

    2/13/26 7:00:00 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hello Group to Report Fourth Quarter and Fiscal Year 2025 Results on March 18, 2026

    BEIJING, Feb. 13, 2026 /PRNewswire/ -- Hello Group Inc. (NASDAQ:MOMO) (the "Company"), a leading player in Asia's online social networking space, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025 before U.S. markets open on Wednesday, March 18, 2026. Hello Group's management will host an earnings conference call on Wednesday, March 18, 2026, at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing / Hong Kong Time on the same day). Preregistration Information Participants can register for the conference call by navigating to https://s1.c-conf.com/diamondpass/10053257-1s7egv.html. Upon registration, each participant w

    2/13/26 6:00:00 AM ET
    $MOMO
    Computer Software: Prepackaged Software
    Technology

    $ABL
    $AGIO
    $AKAN
    $APDN
    Leadership Updates

    Live Leadership Updates

    View All

    Celsius Holdings Appoints Christy Jacoby and John Short to the Company's Board of Directors

    Celsius Holdings, Inc. (NASDAQ:CELH) ("Celsius Holdings" or "the Company") today announced the appointment of Christy Jacoby and John Short to its Board of Directors. Jacoby and Short were nominated by PepsiCo, Inc. ("PepsiCo") following the resignation of Israel Kontorovsky and Michael Del Pozzo from the Celsius Holdings Board, effective immediately. "We thank Israel and Mike for their service and contributions during an important period of growth and evolution for Celsius Holdings," said John Fieldly, Chairman and Chief Executive Officer of Celsius Holdings. "As we continue to scale with discipline, operating rigor and portfolio clarity, we believe Christy and John bring highly relevant

    2/10/26 4:30:00 PM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Cineverse and GameStop Invite Fans to 'Return to Silent Hill' with Innovative Partnership featuring Mysterious Messages, Exclusive Rewards, In-Store Media & More

    Return to Silent Hill Hits Theaters Nationwide on January 23 – Buy Tickets Now LOS ANGELES and GRAPEVINE, Texas, Jan. 14, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next generation entertainment studio, and GameStop Corp. (NYSE:GME), are pulling out all the stops in anticipation of the January 23 wide theatrical release of Return to Silent Hill (returntosilenthillmovie.com).  The two companies are collaborating on an immersive marketing campaign for the new film, based on the visionary video game, SILENT HILL 2. Since January 7, fans who visit a participating GameStop ca

    1/14/26 3:02:00 PM ET
    $CNVS
    $GME
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Electronics Distribution

    $ABL
    $AGIO
    $AKAN
    $APDN
    Financials

    Live finance-specific insights

    View All

    Hello Group to Report Fourth Quarter and Fiscal Year 2025 Results on March 18, 2026

    BEIJING, Feb. 13, 2026 /PRNewswire/ -- Hello Group Inc. (NASDAQ:MOMO) (the "Company"), a leading player in Asia's online social networking space, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025 before U.S. markets open on Wednesday, March 18, 2026. Hello Group's management will host an earnings conference call on Wednesday, March 18, 2026, at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing / Hong Kong Time on the same day). Preregistration Information Participants can register for the conference call by navigating to https://s1.c-conf.com/diamondpass/10053257-1s7egv.html. Upon registration, each participant w

    2/13/26 6:00:00 AM ET
    $MOMO
    Computer Software: Prepackaged Software
    Technology

    DraftKings Reports Fourth Quarter Revenue Growth of 43%

    BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- DraftKings Inc. (NASDAQ:DKNG) ("DraftKings" or the "Company") today announced its fourth quarter and fiscal year 2025 financial results. The Company also posted a letter to shareholders and an earnings presentation on the Investor Relations section of its website at investors.draftkings.com. Fourth Quarter 2025 HighlightsFor the three months ended December 31, 2025, DraftKings reported revenue of $1,989 million, an increase of $596 million, or 43%, compared to $1,393 million during the same period in 2024. The increase in the Company's fourth quarter 2025 revenue was driven primarily by continued healthy customer engagement, efficient acquisition

    2/12/26 4:15:00 PM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Celsius Holdings Announces CAGNY Conference Participation and Fourth Quarter and Full-Year 2025 Earnings Release Date

    Executives will present at the Consumer Analyst Group of New York (CAGNY) Conference on Feb. 19, 2026 Company will release its fourth quarter and full-year 2025 financial results followed by an investor conference call on Feb. 26, 2026 Celsius Holdings, Inc. (NASDAQ:CELH) (the "Company") announced today that John Fieldly, Chairman and CEO, Eric Hanson, President and Chief Operating Officer, and Kyle Watson, Chief Brand Officer, will present at the Consumer Analyst Group of New York (CAGNY) Conference at 5 p.m. ET on Thursday, Feb. 19, 2026. A live webcast of the presentation will be available on the Company's investor relations website at https://ir.celsiusholdingsinc.com. The Company

    2/12/26 4:05:00 PM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    $ABL
    $AGIO
    $AKAN
    $APDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D filed by Exicure Inc.

    SC 13D - EXICURE, INC. (0001698530) (Subject)

    11/29/24 5:51:28 PM ET
    $XCUR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Ocean Power Technologies Inc.

    SC 13G/A - Ocean Power Technologies, Inc. (0001378140) (Subject)

    11/27/24 1:43:24 PM ET
    $OPTT
    Electric Utilities: Central
    Utilities